CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 478 enrolled
Drug / intervention
Fluad Vaccine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03694808
NCT03694808Phase 4Completed
CompareCT.gov

Non-inferiority Study of Adjuvanted vs. High Dose Flu Vaccine in Residents of Long Term Care

David H. Canaday·interventional·Posted Oct 3, 2018·Updated Apr 30, 2024

In Brief

A Phase 4 clinical trial evaluating Fluad Vaccine and Fluzone HD Vaccine for Flu. Completed, enrolled 478 participants across 2 sites.

Detailed Summary

Adjuvanted flu vaccine, Fluad, is not immunologically inferior to HD influenza vaccine in older persons living in long-term care.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFlu
CountriesUnited States
CollaboratorsCase Western Reserve University, US Department of Veterans Affairs, Brown University, National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID)

Timeline

Phase 4CompletedFinished
20192020202120222023202420252026
First PostedOct 3, 2018
Enrollment StartSep 23, 2018
Primary CompletionJan 31, 2023
TodayJul 2, 2026
Enrollment to primary: 4.4 yearsPosted 7.7 years ago

Interventions

Fluad Vaccinedrug

single adjuvanted dose (AD) intramuscular injection

Fluzone HD Vaccinedrug

single high dose (HD) intramuscular injection